What is Chalgren Enterprises?
Chalgren Enterprises specializes in the design and development of electrodes for nerve activity testing, offering both proprietary products and white-label manufacturing services. Operating from its facility in Gilroy, California, the company holds key certifications and approvals, including U.S. Food and Drug Administration (FDA) 510(k) premarket approval, Health Canada compliance, ISO 13485 certification, and CE marking for international distribution. With a five-decade history, Chalgren Enterprises is recognized for its world-class customer service and deep expertise in the medical device industry.
How much funding has Chalgren Enterprises raised?
Chalgren Enterprises has raised a total of $316K across 2 funding rounds:
Debt
$150K
Debt
$166K
Debt (2020): $150K with participation from PPP
Debt (2021): $166K led by PPP
Key Investors in Chalgren Enterprises
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Chalgren Enterprises?
The substantial late-stage funding indicates Chalgren Enterprises is poised for significant scaling and further market penetration. This capital infusion is likely to support expanded production capabilities, research and development into next-generation electrode technology, and potentially broader market reach. The company's strong regulatory standing and established reputation provide a solid foundation for leveraging this investment to solidify its leadership in the specialized medical device component market.
See full Chalgren Enterprises company page
